A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients

NCT00568802 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG: Hydroxyurea
DRUG: Placebo to match hydroxyurea

Sponsor

Stanford University